EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting UGCG sensitizes AML cells to venetoclax through RAB32-mediated endoplasmic reticulum-mitochondria communication

Xiaofan Sun, Yue Li, Danqi Pan, Caiping Wu, Weihao Xiao, Ganlu Feng, Nianhui Yang, Yizhen Li, Wei Xiong, Min Dai, Zhirou Zhang, Lei Hua und 9 weitere

Cell Reports · 2026

DOI: 10.1016/j.celrep.2026.117021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Xiaofan Sun und 20 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Jinan University, Guangzhou, China; Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Acad…. Hauptthemen laut MEDLINE: Sulfonamides, Bridged Bicyclo Compounds, Heterocyclic, Endoplasmic Reticulum, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangdong Provincial People's Hospital, National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uridine diphosphate (UDP)-glucose ceramide glucosyltransferase (UGCG) is an enzyme that glycosylates ceramide and blunts its pro-apoptotic activity in cancer cells. Targeting UGCG sensitizes solid cancer cells to chemotherapy. However, whether targeting UGCG can sensitize acute myeloid leukemia (AML) cells to venetoclax remains unclear. Here, we found that the inhibition of UGCG genetically or with its inhibitor eliglustat efficiently suppressed growth and promoted apoptosis in AML cells. Moreover, eliglustat in combination with venetoclax increased apoptosis, reduced AML cell viability, and inhibited AML effectively both for primary AML cells and xenograft models. Mechanistically, the combination induced ceramide accumulation, which activated the endoplasmic reticulum (ER) stress-GRP78/PERK/CHOP axis. Interestingly, combinatory treatment activated RAB32, which led to mitochondrial fission through ER-mitochondria communication and DRP1 activation. These findings demonstrate that targeting UGCG in combination with venetoclax is an alternative combinatory strategy to treat AML and provide insights into ceramide-mediated cell death in anti-cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesBridged Bicyclo Compounds, HeterocyclicEndoplasmic ReticulumLeukemia, Myeloid, AcuteMitochondriaGlucosyltransferasesrab GTP-Binding ProteinsHumansAnimalsEndoplasmic Reticulum Chaperone BiPCell Line, TumorMiceApoptosisCeramidesEndoplasmic Reticulum StressFemaleXenograft Model Antitumor Assays

Stichwörter der Autor:innen

CP: cancerDRP1RAB32UGCGacute myeloid leukemiaceramide accumulationendoplasmic reticulum stressvenetoclax

Substanzen

SulfonamidesBridged Bicyclo Compounds, HeterocyclicvenetoclaxHSPA5 protein, humanEndoplasmic Reticulum Chaperone BiPceramide glucosyltransferaseGlucosyltransferasesHspa5 protein, mouserab GTP-Binding ProteinsCeramides

Autor:innen und Institutionen

  • The First Affiliated Hospital of Jinan University, Guangzhou, China; Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Chin…
  • The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Department of Oncology, Guangzhou Hospital of Integrated Traditional and Western Medicine, Guangzhou, China.
  • NHC Key Laboratory of Carcinogenesis and Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and Xiangya School of Basic Medicine Sciences, Central South…
  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing, China.

Förderung

  • Guangdong Provincial People's Hospital
  • National Natural Science Foundation of China
  • Guangdong Provincial Natural Science Foundation

Zitieren

APA

Sun, X., Li, Y., Pan, D., Wu, C., Xiao, W., Feng, G., Yang, N., Li, Y., Xiong, W., Dai, M., Zhang, Z., Hua, L., Zhong, L., Yu, G., Geng, S., Deng, C., Luo, C., Wu, P., Du, X., …, & Zeng, H. (2026). Targeting UGCG sensitizes AML cells to venetoclax through RAB32-mediated endoplasmic reticulum-mitochondria communication. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117021

Vancouver

Sun X, Li Y, Pan D, Wu C, Xiao W, Feng G, et al. Targeting UGCG sensitizes AML cells to venetoclax through RAB32-mediated endoplasmic reticulum-mitochondria communication. Cell Reports. 2026. doi:10.1016/j.celrep.2026.117021

BibTeX
@article{Sun2026,
  author = {Sun, Xiaofan and Li, Yue and Pan, Danqi and Wu, Caiping and Xiao, Weihao and Feng, Ganlu and Yang, Nianhui and Li, Yizhen and Xiong, Wei and Dai, Min and Zhang, Zhirou and Hua, Lei and Zhong, Liye and Yu, Guopan and Geng, Suxia and Deng, Chengxin and Luo, Chengwei and Wu, Ping and Du, Xin and Du, Juan and Zeng, Hui},
  title = {Targeting UGCG sensitizes AML cells to venetoclax through RAB32-mediated endoplasmic reticulum-mitochondria communication},
  journal = {Cell Reports},
  year = {2026},
  doi = {10.1016/j.celrep.2026.117021}
}
Kostenlos starten →